Modus Therapeutics

Developers of polysaccharide based drug for the treatment of Sickle Cell Disease

placeStockholm, Stockholm County, Sweden calendar_todayFounded 2011 groups2 employees language modustx.com

Innovation

7 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 80 times.

YearFilings
20141
20171
20182
20191
20211
20221
20233
20243
20252

Social engagement

Social engagement: 736 social following, 10 posts in the last 12 months — around the industry typical range.

Investor mix

6 investors on record; lead investors include The Foundation for Baltic and East European Studies, Praktikertjänst, Healthcap.

Investor typeCountShare
Venture capital583%
Other / undisclosed117%

Recent activity

12 Jun 2026
Event
EHA2026
26 May 2026
Milestone
Coming soon